Novel Immune Checkpoint Inhibitor and Antibody–Drug Conjugate Approaches in the Perioperative Management of Muscle-Invasive Bladder Cancer

Immune checkpoint inhibitors and antibody drug conjugate combinations have revolutionized the management of patients with advanced and metastatic urothelial carcinoma, offering unprecedented survival outcomes. These treatments are now moving into earlier stages of disease, including perioperative tr...

Cijeli opis

Bibliografski detalji

Glavni autori:	Joseph Vento, Tian Zhang, Yair Lotan, Solomon Woldu, Qian Qin
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2026-03-01
Serija:	Current Oncology
Teme:	muscle-invasive bladder cancer urothelial cancer immunotherapy immune checkpoint inhibitors antibody–drug conjugates perioperative systemic therapy
Online pristup:	https://www.mdpi.com/1718-7729/33/3/162
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!